X-151621001-T-G
Variant summary
Our verdict is Likely benign. The variant received -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_173493.3(PASD1):c.279T>G(p.Ile93Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000175 in 1,199,199 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 8 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_173493.3 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -6 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00000896 AC: 1AN: 111650Hom.: 0 Cov.: 23 show subpopulations
GnomAD2 exomes AF: 0.0000398 AC: 7AN: 175908 AF XY: 0.0000819 show subpopulations
GnomAD4 exome AF: 0.0000184 AC: 20AN: 1087549Hom.: 0 Cov.: 27 AF XY: 0.0000226 AC XY: 8AN XY: 353893 show subpopulations
GnomAD4 genome AF: 0.00000896 AC: 1AN: 111650Hom.: 0 Cov.: 23 AF XY: 0.00 AC XY: 0AN XY: 33846 show subpopulations
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.279T>G (p.I93M) alteration is located in exon 5 (coding exon 4) of the PASD1 gene. This alteration results from a T to G substitution at nucleotide position 279, causing the isoleucine (I) at amino acid position 93 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at